360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Biological Defense

Type: Keyphrase

Name: Biological Defense

First reported 6 hours ago - Updated 6 hours ago - 1 reports

U S Defense Threat Reduction Agency

William Florence, DTRA, To Present on Biodefense Vaccines at GTC's Vaccines Conf., July 8-10, Boston

/24-7PressRelease/ -- William Florence, Acting Branch Chief for Vaccines in the Translational Medical Division at the Defense Threat Reduction Agency, will present on "Current Biodefense Vaccine Programs and Challenges" at GTC's 11th Vaccines Research ... [Published 24-7PressRelease.com - 6 hours ago]

Entities: U S Defense Threat Reduction Agency, GTCBio, Florence

First reported May 22 2013 - Updated 9 hours ago - 6 reports

Soligenix gets key Thermovax technology U.S. patent

Soligenix (OTCQB:SNGX) shares extended their year-to-date gains on Wednesday after the biopharmaceutical company announced that it has been granted a U.S. patent for its Thermovax vaccine thermostabilization technology.The company, which is focused on ... [Published Proactive Investors.co.uk - May 22 2013]

Entities: Vaccine, Patent, Biological Defense, Countermeasures, Aluminium

First reported May 22 2013 - Updated May 22 2013 - 1 reports

William Florence, DTRA, To Present on Biodefense Vaccines at GTCs Vaccines Conf., July 8-10, Boston

William Florence, DTRA, To Present on Biodefense Vaccines at GTC’s Vaccines Conf., July 8-10, BostonRelease Date: 2013-05-21William Florence, Acting Branch Chief for Vaccines in the Translational Medical Division at the Defense Threat Reduction Agency, ... [Published PR Urgent - May 22 2013]

Entities: U S Defense Threat Reduction Agency, Florence, Vaccine, Biological Defense, Boston (Massachusetts, United States)

First reported May 22 2013 - Updated May 22 2013 - 1 reports

SAIC to provide support services for JPEO-CBD

Science Applications International Corporation (SAIC) has been awarded a prime contract for provision of support services to the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD).Seeking the supply of programme, engineering, ... [Published Army Technology - May 22 2013]

Entities: SAIC Inc, Biological Defense, Chemical, IDIQ Indefinite Delivery Indefinite Quantity

First reported May 21 2013 - Updated May 21 2013 - 2 reports

SAIC Inc

JPEO-CBD awards contract to SAIC

Science Applications International Corporation announced on Monday that it was awarded a prime contract by the Joint Program Executive Office for Chemical and Biological Defense for program, engineering, medical and technical support services.The three-year ... [Published BioPrepWatch - May 21 2013]

Entities: SAIC Inc, Wins Contract, Biological Defense, National Security

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Navigant Consulting Inc

SAIC Wins New Contract Zacks

SAIC, Inc (SAI) recently procured a prime contract worth $495 million from the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD). SAIC will be providing program, engineering, medical, and technical support services under the ... [Published Yahoo! Finance - May 21 2013]

Entities: SAIC Inc, Wins Contract, National Security, Navigant Consulting Inc

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Human Genome Sciences Inc

Anthrax drug brings $334 million to Pentagon advisor’s biotech firm

WASHINGTON — Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called ... [Published Wichita Falls Times Record News - May 21 2013]

Entities: Richard Danzig, Anthrax, Human Genome Sciences Inc, Biological Defense, Biological terrorism

First reported May 21 2013 - Updated May 21 2013 - 1 reports

That Anthrax Scare

Recently by : The of a Pentagon advisor who lined his own pockets while creating an imagined scenario where currently available antibiotics would be ineffective due to germ resistance, requiring a back up plan a multi-million dollar drug that has cost ... [Published LewRockwell.com - May 21 2013]

Entities: Anthrax, Antibiotic, Antibiotic-Resistant, FBI Federal Bureau of Investigation, Steven J Hatfill

First reported May 21 2013 - Updated May 21 2013 - 2 reports

SAIC Wins Chem-and-Bio Defense Contract

Filed under: InvestingSAIC is helping to keep America safe from chemical and biological weapons. The only question is how much help it will be allowed to give.On Monday, SAIC announced that it has won one of "multiple" awards to provide program, engineering, ... [Published Daily Finance - May 21 2013]

Entities: IDIQ Indefinite Delivery Indefinite Quantity, Motley Fool, BASE PERIOD, Rich Smith

First reported May 20 2013 - Updated May 21 2013 - 4 reports

Pentagon adviser quietly pocketed biotech's cash while promoting its interests

The Los Angeles Times points a bright spotlight on the role former Navy Secretary and biowarfare consultant Richard Danzig played in successfully urging the U.S. government to invest hundreds of millions of dollars in a new therapy developed by Human ... [Published FierceBiotech - May 20 2013]

Entities: Richard Danzig, Anthrax, Biological Defense

First reported May 16 2013 - Updated May 17 2013 - 2 reports

US government awards antibody development contract to AnaptysBio

The US government has awarded a contract to AnaptysBio for the development of highly thermostable anti-ricin antibodies for biodefense applications. ... [Published PBR - News - May 17 2013]

Entities: AnaptysBio Inc, Antibody, United States Government

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Kan. negotiators agree on biodefense lab bonds

TOPEKA, Kan. --Kansas House and Senate budget negotiators have agreed to authorize issuing $202 million in bonds to build a federal biodefense research lab in Manhattan.Negotiators agreed Thursday to allow the state to issue the bonds.Kansas previously ... [Published South Carolina Enquirer-Herald - May 16 2013]

Entities: Biological Defense, Kansas State University, Sam Brownback

Quotes

...By tracking the size and price of each montha'a "s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin."

RSG, FTEK, DSGX, UVSP, ARE, ORCL Are Seasonally Ripe To Go Up In the Next Five Weeks [Published TradingCharts.com - 8 hours ago]

...is compatible with many different monoclonal antibody-based therapies and may offer a general solution to JCV infection as a companion therapeutic. "JCV infection progresses to PML only in patients with chronic or drug-induced immune suppression. The ability to clear JCV infection in at least some patients is encouraging. Further clinical evaluation confirming preliminary results is underway in several patient groups" said Milton H Werner PhPh D , Chief Executive Officer and President of Inhibikase Therapeutics

Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal ... [Published TickerTech.com - 8 hours ago]

...to our growing pipeline of drug-eluting stent technologies," said Kevin Ballinger, president, Interventional Cardiology, Boston Scientific. "These innovations reflect our commitment to interventional cardiologists and the patients they serve."

Boston Scientific Announces Results from Promus Premier; Salix's Budesonide Foam Shows Significan ... [Published BioMedReports - 17 hours ago]

...Danzig addressed a conference at Washington's Willard Hotel on July 28, 2011, he reiterated some of his original assertions about Aum Shinrikyo: "So why didn't they succeed with the anthrax? They had difficulties with transduction" the technical term for combining plasmids from the two strains

Bioterrorism consultant's anthrax claim challenged [Published Los Angeles Times - 19 hours ago]

More Content

sort by: Date \| Relevance
William Florence, DTRA, To Present on Biodefens... [Published 24-7PressRelease.com - 6 hours ago]
RSG, FTEK, DSGX, UVSP, ARE, ORCL Are Seasonally... [Published TradingCharts.com - 8 hours ago]
Inhibikase Therapeutics to present at Industry ... [Published TickerTech.com - 8 hours ago]
William Florence, DTRA, to Present on Biodefens... [Published PR.com Press Releases - 13 hours ago]
Boston Scientific Announces Results from Promus... [Published BioMedReports - 17 hours ago]
Bioterrorism consultant's anthrax claim challenged [Published Los Angeles Times - 19 hours ago]
Soligenix gets key Thermovax technology U.S. pa... [Published Proactive Investors.co.uk - May 22 2013]
Soligenix gets key Thermovax technology U.S. pa... [Published Proactiveinvestors United Kingdom RSS feed - May 22 2013]
Soligenix gets key Thermovax technology U.S. pa... [Published Proactiveinvestors United Kingdom RSS feed - May 22 2013]
Soligenix gets key Thermovax technology U.S. pa... [Published Proactive Investors USA - May 22 2013]
William Florence, DTRA, To Present on Biodefens... [Published PR Urgent - May 22 2013]
Cleveland BioLabs to Present at Second Annual M... [Published Barchart - May 22 2013]
Navy Evaluates Collective Protection in Expedit... [Published Navy News Stand - May 22 2013]
SAIC to provide support services for JPEO-CBD [Published Army Technology - May 22 2013]
Soligenix Announces Issuance of US Patent for i... [Published Zecco - May 22 2013]
Soligenix Announces Issuance of US Patent for i... [Published TickerTech.com - May 22 2013]
Soligenix Announces Issuance of US Patent for i... [Published PR Newswire: Policy & Public Interest - May 22 2013]
Mirari Biosciences Granted U.S. Patent for Micr... [Published PRWeb - May 22 2013]
William Florence, DTRA, To Present on Biodefens... [Published PR inside - May 22 2013]
JPEO-CBD awards contract to SAIC [Published BioPrepWatch - May 21 2013]
Luminex's CEO Presents at UBS Global Healthcare... [Published Seeking Alpha - May 21 2013]
Slater Leverages Federal Funding to Invest $3.5... [Published Slater Technology Fund - May 21 2013]
SAIC Wins New Contract Zacks [Published Yahoo! Finance - May 21 2013]
Anthrax drug brings $334 million to Pentagon ad... [Published Wichita Falls Times Record News - May 21 2013]
That Anthrax Scare [Published LewRockwell.com - May 21 2013]
SAIC Awarded Contract By JPEO-CBD [Published ASDNews.com: Be the first to know - May 21 2013]
SAIC Wins Chem-and-Bio Defense Contract [Published Daily Finance - May 21 2013]
Aeolus Pharmaceuticals, Inc. (AOLS) - Pharmaceu... [Published TransWorldNews - May 21 2013]
SAIC Wins Chem-and-Bio Defense Contract [Published Motley Fool - May 21 2013]
National Science Foundation-Funded Researchers ... [Published National Science Foundation - May 20 2013]

Blogs

sort by: Date \| Relevance
CNN Washington AM Note [Published CNN Political Ticker - May 20 2013] BREAKING OVERNIGHT: CNN: North Korea fires another projectile into the sea off its east coast, South says North Korea on Monday fired a projectile into the sea off its east coast for the third day in a row, South Korean officials said, urging ...
And I bet he wants his income taxes cut too [Published Firedoglake - May 20 2013] Ah, the “War on Terror” has anything ever been more profitable ? Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, ...
US government awards antibody development contr... [Published PBR - News - May 17 2013] The US government has awarded a contract to AnaptysBio for the development of highly thermostable anti-ricin antibodies for biodefense applications. ...
Humanoid Robot Testing by Boston Dynamics [Published Michele Kearney's Nuclear Wire - Apr 08 2013] Humanoid Robot Testing by Boston Dynamics http://www.darkgovernment.com/news/humanoid-robot-testing-by-boston-dynamics/ Defense contractor Boston Dynamics has new video of its Terminator-like“PETMAN” robot standing, walking, posing and… wearing a che ...
US: Stockpiling a smallpox drug [Published H5N1 - Mar 13 2013] Via The New York Times: U.S. Stockpiles Smallpox Drug in Case of Bioterror Attack. Excerpt from a bizarre report:The United States government is buying enough of a new smallpox medicine to treat two million people in the event of a bioterrorism attack, ...

Audio/Video

sort by: Date \| Relevance
Gerald Parker [Published BIO Channel - YouTube - May 03 2013]

Press Releases

sort by: Date \| Relevance
William Florence, DTRA, to Present on Biodefens... [Published PR.com Press Releases - 13 hours ago]
Soligenix Announces Issuance of US Patent for i... [Published PR Newswire: Policy & Public Interest - May 22 2013]
William Florence, DTRA, To Present on Biodefens... [Published PR inside - May 22 2013]
AnaptysBio Awarded U.S. Government Contract To ... [Published Auto & Transportation - May 16 2013]
Soligenix Initiates Phase 1 Clinical Study with... [Published PR Newswire - May 15 2013]